"Promising Results: Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial"

In a small trial, nearly a third of advanced liver cancer patients who received a personalized vaccine developed by Geneos Therapeutics alongside an immunotherapy drug saw their tumors shrink, a response twice as high as with immunotherapy alone. The vaccine, based on mutations specific to each patient's tumor, aims to boost the immune system's ability to recognize and attack hard-to-treat cancers. The study suggests progress towards effective cancer vaccines and potential expansion to treat various cancer types, with promising results in combining customized vaccines with immunotherapy. Larger trials are being planned to confirm these findings.